Skip Navigation

European Heart Journal 1992 13(Supplement D):44-49; doi:10.1093/eurheartj/13.suppl_D.44
Copyright © 1992 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vogt, M.
Right arrow Articles by Strauer, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogt, M.
Right arrow Articles by Strauer, B. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 The European Society of Cardiology

Coronary haemodynamics in hypertensive heart disease

M. Vogt, W. Motz and B. E. Strauer

Medical Clinic B, Heinrich-Heine-University of Düsseldorf Germany

Address for correspondence: : Martin Vogt, MD, Medizinische Einrichtungen der Heinrich-Heine-Universität Düsseldorf, Medizinische Klinik und Poliklinik B, Abteilung für Kardiologie. Pneumologie und Angiologie, Moorenstr. 5, D-4000 Düsseldorf 1, Germany

Cardiac constituents affected in arterial hypertension comprise the myocardium, interstitium and coronary circulation. With regard to coronary circulation, arterial hypertension is an important risk factor in coronary artery disease, but even in the absence of coronary artery disease, hypertensive patients frequently have angina pectoris or reveal electrocardiographic abnormalities suggestive of myocardial ischaemia due to coronary insufficiency. Under clinical conditions, determination of coronary flow reserve (dipyridamole; Argon-method) allows for the evaluation of impairment of coronary regulatory reserve. In comparison to healthy normotensives, coronary haemodynamics in hypertensive patients with microvascular angina are characterized by a severely increased minimal coronary resistance and reduced maxmial coronary blood flow to dipyridamole. Accordingly, coronary reserve is markedly reduced by about 40%, and metabolic, myocardial and vascular factors may be involved in this reduction. In the compensated stage of arterial hypertension, with concentric left ventricular hypertrophy, myocardial factors, such as myocyte hypertrophy, extravascular compressing forces and functional implications of impaired relaxation, as well as metabolic factors, contribute to impairment in coronary reserve to a minor extent. The reduction in coronary flow reserve is not proportional to the elevation in left ventricular muscle mass and thus the degree of left ventricular hypertrophy does not seem to determine the reduction in vasodilator reserve directly. Thus the reduction in coronary reserve seems to be primarily the consequence of an impaired vasodilating capacity of the coronary resistance vessels, as indicated by a severely increased minimum coronary resistance to dipyridamole, i.e. a severely reduced overall coronary conductance capacity. Structural changes of the small coronary resistance vessels, such as medial thickening and perivascular fibrosis, might therefore play a key role in the pathophysiological-anatomical background of the impaired coronary reserve. With the occurrence of chamber enlargement, increased systolic wall stress may also restrict coronary reserve metabolically, and increased diastolic wall stress by an increment in extravascular compressive force. Finally, at the coronary microcirculation level coronary insufficiency in hypertensive patients with angina pectoris and normal coronary angiogram may also be due to impairment of the endothelium-dependent vasodilation of the small resistance vessels.

Key Words: Coronary circulation • coronary vasodilator reserve • medial hypertrophy • left ventricular hypertrophy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
P. G. Camici and F. Crea
Coronary Microvascular Dysfunction
N. Engl. J. Med., February 22, 2007; 356(8): 830 - 840.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.